USPTO 2015–2025 USPTO PatentsView US Corporation

Epitel, Inc.

USPTO PatentsView assignee record - 14 granted patents across 5 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Epitel ranks #19,725 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 5 technology areas.

#19,725
of 49,997 US assignees by volume
Top 16%
by Innovation Score (48.8/100)
19.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R19725 · US Corporation #19,725 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 14 grants
  • MID-PACK #19,725/49,997
  • PHOTO-FINISH Elmich Pte
  • CPC-NARROW A61B · 5 areas
  • INNOV-PAR 48.8/100
  • CLAIMS-RICH 19.2 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2021–2025 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Elmich Pte Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Epitel’s 48.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Epitel

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Epitel's Innovation Score is 48.8/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Epitel?

Each dot is one of Epitel’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Epitel’s own 19.2 claims/patent is ABOVE the 15.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Epitel vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 13.913.91414.1 0102030 Granted patents (volume) Avg claims / patent Elmich Pte Ltd - 14, 2Elmich PteEluvio, Inc. - 14, 28.57EluvioEmbertec Pty Ltd - 14, 14.57Embertec PtyEmotiv Inc. - 14, 18.57EmotivEpoca International, Inc. - 14, 2.29Epoca Internation…Erdman Automation Corporation - 14, 15.93Erdman AutomationEriez Manufacturing Co. - 14, 19Eriez Manufacturi…Essentium Inc. - 14, 16.43EssentiumEpitel, Inc. - 14, 19.21Epitel
Epitel vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Epitel's grants concentrate

Epitel, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (5 grants) versus a trough of 1 in 2021. By volume, Epitel sits between Elmich Pte Ltd and Essentium Inc..

Epitel's three-year grant acceleration

Epitel, Inc. shows 10 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Epitel's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Epitel holds 14 patents at rank #19,740, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Epitel

By rank, the assignees closest to #19,740 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Epitel's primary technology class.

Epitel's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 2021202320242025 3
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
Epitel, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 1 7.1%
2023 5 35.7%
2024 5 35.7%
2025partial year 3 21.4%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Epitel, Inc.'s patent record in context - here's where to go next.

  • Epitel, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #19,725 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Epitel, Inc. against Elmich Pte Ltd, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 48.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.